Cantor Fitzgerald analyst Elemer Piros reiterated and an Overweight rating and $14 price target on Strongbridge Biopharma (NASDAQ: SBBP), following ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE